Trial Profile
Arimidex [anastrozole] study (non-interventional study to evaluate Arimidex in adjuvant therapy in partial or complete response or stabilized disease after first line chemotherapy in postmenopausal women with advanced breast cancer)
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 12 Feb 2013
Price :
$35
*
At a glance
- Drugs Anastrozole (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Sponsors AstraZeneca
- 13 Dec 2007 New trial record.